Cingulate Inc. Share Price
CINGCingulate Inc. Stock Performance
Open $4.45 | Prev. Close $4.57 | Circuit Range N/A |
Day Range $4.45 - $4.61 | Year Range $3.19 - $11.78 | Volume 4,193 |
Average Traded $4.55 |
Cingulate Inc. Share Price Chart
About Cingulate Inc.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $4.45 | $4.58 | +0.00% |
20-Jul-26 | $4.45 | $4.58 | +0.44% |
17-Jul-26 | $4.32 | $4.56 | +2.93% |
16-Jul-26 | $4.43 | $4.43 | -4.11% |
15-Jul-26 | $4.75 | $4.62 | -2.53% |
14-Jul-26 | $4.71 | $4.74 | +1.17% |
13-Jul-26 | $4.84 | $4.68 | -4.58% |
FAQs on Cingulate Inc. Share Price
Can I buy Cingulate Inc. shares in India?
What is the share price of Cingulate Inc.?
What is the 5 year returns of Cingulate Inc.?
What are the high & low stock price of Cingulate Inc. today?
What is the 52-week high and low of Cingulate Inc. stock?